MED13L-related intellectual disability due to paternal germinal mosaicism

The MED13L-related intellectual disability or MRFACD syndrome (Mental retardation and distinctive facial features with or without cardiac defects; MIM # 616789) is one of the most common forms of syndromic intellectual disability with about a hundred cases reported so far. Affected individuals share overlapping features comprising intellectual disability, hypotonia, motor delay, remarkable speech delay, and a recognizable facial gestalt. De novo disruption of the MED13L gene by deletions, duplications, or sequence variants has been identified as deleterious. Siblings affected by intragenic deletion transmitted from a mosaic parent have been reported once in the literature. We now present the first case of paternal germinal mosaicism for a missense MED13L variant causing MRFACD syndrome in one of the father's children and being the likely cause of intellectual disability and facial dysmorphism in the other. As part of the Mediator complex, the MED proteins have an essential role in regulating transcription. Thirty-two subunits of the Mediator complex genes have been linked to congenital malformations that are now acknowledged as transcriptomopathies. The MRFACD syndrome has been suggested to represent a recognizable phenotype.

[1]  B. Wlodarczyk,et al.  Somatic and de novo Germline Variants of MEDs in Human Neural Tube Defects , 2021, Frontiers in Cell and Developmental Biology.

[2]  R. Płoski,et al.  The MED13L Haploinsufficiency Syndrome Associated with De Novo Nonsense Variant (P.GLN1981*) , 2020, Journal of mother and child.

[3]  David R. Murdock,et al.  Community‐based recruitment and exome sequencing indicates high diagnostic yield in adults with intellectual disability , 2020, Molecular genetics & genomic medicine.

[4]  Zhenfeng Song,et al.  Report of a de novo c.2605C > T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability , 2020, Italian Journal of Pediatrics.

[5]  D. Scheinost,et al.  De novo damaging variants associated with congenital heart diseases contribute to the connectome , 2020, Scientific Reports.

[6]  A. Takata,et al.  Comprehensive genetic analysis of 57 families with clinically suspected Cornelia de Lange syndrome , 2019, Journal of Human Genetics.

[7]  M. Larsen,et al.  Is MED13L-related intellectual disability a recognizable syndrome? , 2019, European journal of medical genetics.

[8]  A. Afenjar,et al.  MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype , 2018, neurogenetics.

[9]  A. Benítez-Burraco,et al.  Language and Cognitive Impairment Associated with a Novel p.Cys63Arg Change in the MED13L Transcriptional Regulator , 2018, Molecular Syndromology.

[10]  N. Boddaert,et al.  MED13L loss‐of‐function variants in two patients with syndromic Pierre Robin sequence , 2018, American journal of medical genetics. Part A.

[11]  R. Schiffmann,et al.  Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation. , 2017, European journal of medical genetics.

[12]  N. Okamoto,et al.  MED13L haploinsufficiency syndrome: A de novo frameshift and recurrent intragenic deletions due to parental mosaicism , 2017, American journal of medical genetics. Part A.

[13]  W. Grody,et al.  Coupling clinical exome sequencing with functional characterization studies to diagnose a patient with familial Mediterranean fever and MED13L haploinsufficiency syndromes , 2017, Clinical case reports.

[14]  Joan,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[15]  Arthur Wuster,et al.  Timing, rates and spectra of human germline mutation , 2015, Nature Genetics.

[16]  B. Gener,et al.  Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders , 2015, Molecular Autism.

[17]  Steven P. Angus,et al.  Redefining the MED13L syndrome , 2015, European Journal of Human Genetics.

[18]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[19]  E. Mercuri,et al.  Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome , 2015, European Journal of Human Genetics.

[20]  J. Lupski,et al.  Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes. , 2015, The Journal of clinical investigation.

[21]  H. Liany,et al.  Impaired Development of Neural‐Crest Cell‐Derived Organs and Intellectual Disability Caused by MED13L Haploinsufficiency , 2014, Human mutation.

[22]  Edouard Henrion,et al.  De Novo Mutations in Moderate or Severe Intellectual Disability , 2014, PLoS genetics.

[23]  Véronique Geoffroy,et al.  Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing , 2014, Journal of Medical Genetics.

[24]  Julia Wynn,et al.  The usefulness of whole-exome sequencing in routine clinical practice , 2014, Genetics in Medicine.

[25]  J. Nevins,et al.  A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest , 2012, Oncogene.

[26]  S. Steinberg,et al.  Rate of de novo mutations and the importance of father’s age to disease risk , 2012, Nature.

[27]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[28]  Wei Chen,et al.  Deep sequencing reveals 50 novel genes for recessive cognitive disorders , 2011, Nature.

[29]  Sohail Malik,et al.  The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation , 2010, Nature Reviews Genetics.

[30]  H. Ropers,et al.  cDNA cloning and characterization of the human THRAP2 gene which maps to chromosome 12q24, and its mouse ortholog Thrap2. , 2004, Gene.

[31]  J. Goodship,et al.  Missense Mutations and Gene Interruption in PROSIT240, a Novel TRAP240-Like Gene, in Patients With Congenital Heart Defect (Transposition of the Great Arteries) , 2003, Circulation.